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@yahoo.Abstract Objective: To compare the histopathological structure and immunohistochemical char-
acteristics of acquired cholesteatoma in children and adults.
Study design: Prospective clinical study in a tertiary care centers.
Material & methods: This study was conducted on 40 patients presenting with cholesteatomatous
middle ear disease. Twenty patients were of a pediatric age group (<18 years) and the rest were
adults (>18 years). Patients were admitted to either the ENT Department of Alexandria University
Hospital or that of the Students’ Hospital. All cholesteatoma specimens were collected intra-
operatively and preserved for histopathological examination and immunohistochemical technique
(PCNA monoclonal antibody).
Results: Histopathological examination of the submitted specimens revealed that strips of strat-
iﬁed squamous epithelium with the underlying tissues were ﬁbrous in adults while cellular inﬂam-
matory inﬁltrates were seen in children. The degree of ﬁbrosis was signiﬁcantly higher in the
adult group. Immunohistochemical examination revealed signiﬁcantly higher expression scores ofEar, Nose, Throat and Allied
evier B.V. All rights reserved.




8 M. Bassiouny et al.the proliferation marker in the pediatric group. In thematrix: The mean of PCNA/LI of adult squa-
mous epithelium was 17.75 ± 12.08 and of children’s cases was 32.82 ± 17.09. In the perimatrix:
The mean of PCNA/LI of adult inﬂammatory inﬁltrate was 14.77 ± 17.28 and in children was
24.22 ± 22.61. The differences of both were statistically signiﬁcant.
Conclusion: The degree of ﬁbrosis was signiﬁcantly higher in adult specimens indicating a repar-
ative process and less invasiveness. PCNA expression was signiﬁcantly higher in the matrix and per-
imatrix of pediatric cholesteatoma as correlated to its increased proliferation. Pediatric
cholesteatoma was more aggressive and invasive than adult cholesteatoma.
ª 2012 Egyptian Society of Ear, Nose, Throat and Allied Sciences.
Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Cholesteatomas are cystlike, expansile lesions of the temporal
bone lined by stratiﬁed squamous epithelium that contains des-
quamated keratin. They most frequently involve the middle ear
and mastoid, but they may develop anywhere within the pneu-
matized portions of the temporal bone. They may be congen-
ital or acquired.1 Acquired cholesteatoma has two varieties
being primary (retraction pocket choleteatoma) or secondary
cholesteatoma. Acquired cholesteatoma of the middle ear is
characterized by an intense inﬂammatory reaction that results
in tissue and bone destruction.2,3 The cholesteatoma is charac-
terized by the presence of a keratinized stratiﬁed squamous
epithelium inside any air-ﬁlled area of the temporal bone.4 His-
tologically, it is composed of multilayered squamous epithe-
lium (matrix) which is surrounded by a mesenchymatous
granulation tissue (perimatrix). The epicenter of the osteolytic
process is located in the contact zone between the matrix and
perimatrix as well as signs for wound healing with the forma-
tion of granulation tissue and capillary multiplication that
ispredominant in the perimatrix.5–8 Cholesteatomas have great
erosion potential, they may reach the ossicular chain, skull
bones and also the hardest bone in the human body, the laby-
rinth. Total or partial ossicle destruction is observed more fre-
quently in patients with cholesteatomas.6,9 Cholesteatomas in
children are frequently observed to demonstrate a more
aggressive growth pattern and higher recurrence rate than
those observed in adults.10 The reason for this increased
aggressiveness is poorly understood.
2. Aim of the work
The aim of this work was to compare the histopathological
structure and immunohistochemical characteristics of acquired
cholesteatoma in children and adults.
3. Material and methods
This study was carried on 40 out of 312 patients (12.8%) pre-
senting with cholesteatomatous middle ear disease fromMarch
2009 to June 2010. They were admitted to the Department of
Otorhinolaryngology in the Alexandria University Hospital
and the Alexandria Students’ Hospital. Twenty patients were
of the pediatric age group (<18 years) and the rest were of
adults’ age group (>18 years).
Patient inclusion criteria in this study obeyed the following:
1. Diagnosis of cholesteatomatous chronic otitis media.2. Matrix and perimatrix presence in the cholesteatoma
collected.
Those patients who presented with congenital cholestea-
toma were excluded from the study.
All patients signed a written consent to participate in the
study. These patients were evaluated with regard to detailed
history, thorough otological examination, full audiological
assessment and CT scan of petrous bone. Patients underwent
tympanomastoidectomy and all cholesteatomas were surgi-
cally removed. Disease extension and ossicular erosion were
assessed. Collected specimens were immediately ﬁxed in 10%
formaldehyde for histopathological examination. Biopsies
were cut into 5 lm thick sections and stained with the follow-
ing stains: H & E for histopathological examination, Masson
Trichrome for the assessment of the degree of ﬁbrosis, and
immunohistochemical technique for PCNA (proliferating cell
nuclear antigen) monoclonal antibody [PC10 (anti-PCNA;
D.B.A Italia s.r.l., Milan, Italy)]. The immunohistochemistry
staining was performed using the peroxidase–antiperoxidase
method.
On day 1: After deparafﬁnization of the sections, they were
dehydrated in descending grades of alcohol till they reached
water. Subsequently, the antigen retrieval step was performed
by boiling the slides in 2% citrate buffer for 10 min in a micro-
wave. Subsequently, they were left to cool down to room tem-
perature. Then they were left to equilibrate in PBS (protein
Buffer Substrate). Subsequently, endogenous peroxidase activ-
ity was blocked using H2O2 blocker by incubation for 10 min.
Then protein block was performed by incubation with protein
block for 5 min. Without intervening washes, the primary anti-
body was added (prediluted). Slides were incubated overnight
at 4 C.
On day 2: Slides were left to rise to room temperature for
1 h. Then the secondary antibody was applied for a period
of 30 min, followed by the labeling agent for another 30 min.
Subsequently, the chromogen diaminobenzidine (DAB) was
applied for 10–15 min. Subsequently, slides were counter-
stained with hematoxylin, dehydrated, cleared and cover
slipped using Canada balsam as a mounting medium.
All incubations were performed at room temperature in a
humidity chamber, unless otherwise stated. Each two succes-
sive steps were separated by 2X washes in PBS.
Positive controls were included with each run.
Fibrosis and inﬂammation were given scores (0–3) accord-
ing to the degree of ﬁbrosis and intensity of inﬂammation.
PCNA/LI (PCNA/Labeling Index) was done by counting
the ratio of positively stained nuclei in the whole slide.
(c)(b)(a)
Figure 1 Section of a case of cholesteatoma showing (a) strip of stratiﬁed squamous epithelium (·200), (b) with a well developed lamellar
keratin layer (·100) and (c) ghost cells (·400) (H & E stain).
Table 1 Comparison between the two studied groups accord-
ing to inﬂammatory inﬁltrate and ﬁbrosis of the prematrix.
Intensity Adult (n= 15) Ped (n= 18) Z (P)
Inf.
Range 1.0–3.0 1.0–3.0 1.161 (0.246)
Mean ± SD 1.53 ± 0.74 1.83 ± 0.79
Median 1.0 2.0
Fibrosis
Range 0.0–3.0 0.0–3.0 2.344 (0.019)*
Mean ± SD 2.13 ± 1.06 1.22 ± 1.0
Median 3.0 1.0
Inf: inﬂammatory inﬁltrate.
Z: Z for Mann–Whitney test.
* Statistically signiﬁcant at P 6 0.05.
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two unpaired groups) was used as statistical test of signiﬁcance
to compare the degree of ﬁbrosis and inﬂammation and PCNA
expression between pediatric and adult specimens. Values of
P 6 0.05 were considered as statistically signiﬁcant.
4. Results
All patients underwent surgery for an acquired middle ear cho-
lesteatoma the operative specimens from 40 patients were col-
lected. There were 20 adults, 7 males and 13 females, average
age of 34.25 years (range 23–50 years); and 20 children, 8 boys
and 12 girls, average age of 13.6 years (range 5–18 years).
The rates of conductive and mixed hearing loss were similar
in both groups. The rate of severe degree of hearing loss was
higher in the pediatric group (50% vs. 20%). Also there was
one case of total hearing loss in the pediatric while there were
no cases of total hearing loss in the adult group.
All patients underwent tympanomastoidectomy surgery,
and disease extension, ossicular erosion, and degree of inva-
sion were ﬁgured out. Specimens of cholesteatoma were col-
lected. Seven specimens were excluded from the study (5 of
the adult group and 2 of the pediatric group) because the tissue
amount was insufﬁcient for histopathological and immunohis-
tochemical assessment (presented only corneal lamellae).
Regarding disease extension and ossicular invasion, in the
pediatric group, there was a greater frequency of extension
of the cholesteatoma into the whole mastoid cavity and middle
ear (40% vs. 20%). The rate of extratemporal extension was
higher in the pediatric group (10% vs. 0%). The rate of
involvement of the whole ossicular chain was similar between
both groups. However, the rate of invasion of the external
auditory canal wall or tegmen was higher in the pediatric
group (35% vs. 10%).
Histopathological microscopic examination of the submit-
ted specimens revealed strips of stratiﬁed squamous epithelium(a) (
Figure 2 The underling tissues were more ﬁbrous in (a) adult cases (·showing no rete ridges (epidermal thickenings that extend
downward between dermal papillae) (Fig. 1a). In some cases,
only the epithelial element was detected with lamellar kerati-
nous contents (Fig. 1b). Ghost squames (keratinized denucle-
ated cells with an unstained, shadowy center where the
nucleus has been) were frequently seen (Fig. 1c). Cellular
dysplasias were not detected. There was normal nuclear to
cytoplasm ratio. The underlying tissues were ﬁbrous in adult
cases (Fig. 2a) as compared to a more cellular inﬂammatory
inﬁltrate (Fig. 2b) in cases of children. The inﬂammatory inﬁl-
trate was mainly composed of lymphocytes, histiocytes as well
as plasma cells.
4.1. Histopathological examination
The degree of ﬁbrosis was signiﬁcantly higher in the adult group
as compared to the pediatric group (Table 1). No differencesb)
100) and more cellular in (b) children’s cases (·200) (H & E stain).
(a) (b)
Figure 3 A case of cholesteatoma of (a) adults (·200) and (b) pediatric group (·400) showing nuclear positivity (red stained) in the
surface epithelium (PCNA monoclonal antibody, peroxidase–antiperoxidase method).
Table 2 Comparison between the two studied groups accord-
ing to PCNA/LI of both matrix and perimatrix.
PCNA/LI Adult (n= 15) Ped (n= 18) Z (P)
Prematrix
Range 0.0–64.0 0.0–76.0 1.628 (0.014)*
Mean ± SD 14.77 ± 17.28 24.22 ± 22.61
Median 9.50 18.90
Matrix
Range 1.0–48.0 8.0–67.0 2.857 (0.004)*
Mean ± SD 17.75 ± 12.08 32.82 ± 17.09
Median 16.0 29.70
Z: Z for Mann–Whitney test.
* Statistically signiﬁcant at P 6 0.05.
10 M. Bassiouny et al.were noted in the degree of inﬂammatory inﬁltrate between
both groups. The mean scores of ﬁbrosis and inﬂammatory
changes in the perimatrix are listed in Table 1.
4.2. Immunohistochemical examination
Cholesteatomas in the pediatric group revealed signiﬁcantly
higher expression scores of the proliferationmarker investigated.
4.1.1. In the matrix
The PCNA/LI of adult squamous epithelium (Fig. 3a) ranged
between 1.0 and 48.0 with a mean of 17.75 ± 12.08. PCNA/LI
of children’s cases (Fig. 3b) ranged between 8.0 and 67.0 with a
mean of 32.82 ± 17.09. The differences between the PCNA/LI
of the adult and children’s matrix were statistically signiﬁcant
(Table 2).Figure 4 Section of two cases of cholesteatoma of an (a) adult (·200
positively staining nuclei (red stained) in both cases (PCNA monoclon4.1.2. In the perimatrix
The PCNA/LI of adult inﬂammatory inﬁltrate (Fig. 4a) ranged
between 0.0 and 64.0 with a mean of 14.77 ± 17.28. PCNA/LI
of children’s cases (Fig. 4b) ranged between 0.0 and 76.0 with a
mean of 24.22 ± 22.61. The differences between the PCNA/LI
of the adult and children’s perimatrix were statistically signif-
icant (Table 2).
5. Clinico-pathological correlation
Pediatric cholesteatoma cases showed more extension and more
invasion than adult cases, which may be correlated with the sig-
niﬁcantly increased expression of PCNA in both the matrix and
perimatrix in the pediatric cases. In addition, the signiﬁcantly
increased ﬁbrosis in the adult cases may be correlated with the
less aggressive cholesteatoma in adults.
There was an impression that cases with higher prolifera-
tion scores (PCNA expression) showed more aggression (great-
er disease extension and greater degree of bone erosion). The
expression of PCNA may be used as a prognostic marker for
the aggressiveness and invasiveness of cholesteatoma.
6. Discussion
Acquired cholesteatoma of the middle ear characteristically
presents with aggressive growth leading to the destruction of
the ossicular chain and other surrounding bony structures. His-
tologically a multilayered squamous epithelium (matrix) is sur-
rounded by a mesenchymatous granulation tissue (perimatrix).
The epicenter of the osteolytic process is located in the contact
zone between the matrix and perimatrix as well as signs for
wound healing with the formation of granulation tissue and
capillary multiplication being predominant in the perimatrix.11) and (b) pediatric (·400) cases. Note the differences in the PCNA
al antibody).
Histopathological and immunohistochemical characteristics of acquired cholesteatoma in children and adults 11Pediatric and adult cholesteatoma may behave in different
ways.10 One might then hypothesize that pediatric and adult
cholesteatomas might represent different spectrums of the
same disease or even a different disease entirely. Clinically, it
is not possible to make distinctions between the more and less
aggressive cholesteatomas. The purpose of this study was to
compare the histopathological structure and immunohisto-
chemical characteristics of acquired cholesteatoma in children
and adults, and consequently their impact on the clinical
behavior.
The pediatric cholesteatoma in the present study demon-
strated a higher incidence of active inﬂammation as evidenced
by having more cellular perimatrix compared to the more ﬁ-
brotic perimatrix in adult cholesteatoma.
In the present study, the examined histopathological speci-
mens of pediatric and adult cholesteatoma revealed that pedi-
atric perimatrix was more cellular in comparison to adult
perimatrix. The degree of ﬁbrosis was signiﬁcantly higher in
the adult specimens, which indicates that the adult cholestea-
toma is more in reparative process and less invasive. No signif-
icant difference was noted in the degree of inﬂammatory
inﬁltration between both groups, which indicates that the com-
position of inﬂammatory inﬁltrate is similar in both groups.
Cellular dysplasia, which is common in neoplastic lesions,
was not detected. The cytogenetic ﬁndings combined with
the histopathological characteristics (i.e. normal nuclear to
cytoplasm ratio) which failed to demonstrate any signs of dys-
plasia, suggest that cellular dysregulation (neoplasia) is not the
critical event in cholesteatoma genesis. These observations
support those of many other investigators.12,13,2
There are numerous studies reviewing the potential etiology
of different behavior of pediatric cholesteatoma. Some investi-
gators compared the histopathological structure of pediatric
and adult cholesteatomas. They compared the histopatholo-
gical components, perimatrix thickness and degree of inﬂamma-
tion between pediatric and adult cholesteatomas. Dornelles
et al.14 showed no differences in the histopathological compo-
nents of acquired cholesteatoma in adults and children. These
results were not similar to the results in the present study. The
signiﬁcantly increased degree of ﬁbrosis may be explained by
more control of infection and inﬂammation in adult cases, bet-
ter compliance and better preoperative preparation by medical
treatment.
Welkoborsky et al.12 could not detect marked differences
between adult and pediatric cholesteatoma on the cellular
level. Dornelles et al.14,15 showed that the degree of inﬂamma-
tion of the perimatrix presented moderate to intense
correlation with the perimatrix thickness. The perimatrix
inﬂammation degree and size, measured in micrometers, pre-
sented an inverse correlation with patient’s age at the time of
the surgery.
There were clues of a greater degree of inﬂammation in
pediatric cholesteatoma. Thus it is suggested that the different
clinical characteristics of pediatric cholesteatoma would be re-
lated to the amount of inﬂammation it causes.15 Dornelles
et al.[16] used matrix thickness as a parameter of comparison
and they found no signiﬁcant difference between both groups.
PCNA is a multifunctional protein with roles in DNA rep-
lication synthesis, DNA repair synthesis and recombination-
driven DNA synthesis. It is a subunit of DNA polymerase,
which has been associated with repair. It acts as sliding clamps
needed for the activity of DNA polymerase and other enzymesfrom the battery used in DNA synthesis. For conclusion,
PCNA has a triple function in the life and death of the cells.
When not engaged in DNA replication, PCNA (most often un-
der the control of p53) commits cells to cell cycle arrest and re-
pair of DNA damage, or, when repair is not possible, absence
or low levels of functional PCNA may drive cells into
apoptosis.17
PCNA has been used in cytological and histological mate-
rial and has recently been reported to provide a simple method
of recognizing proliferating cells in methacarn or alcohol ﬁxed,
wax embedded tissue, with results comparable with those
achieved with ﬂow cytometry.18 Therefore, it would also allow
retrospective assessment of the proliferative rates in archival
tissues due to the conservation of this marker in ﬁxed and par-
afﬁn-embedded tissues.19
PCNA expression was also tested in middle ear cholestea-
toma. Olszewska et al.20 used PCNA as a marker of prolifera-
tion in cholesteatoma. He found that its expression is
signiﬁcantly higher compared to normal postauricular skin.
Shieh et al.21 also showed similar results. Other studies also
conﬁrmed these results.22
These studies also showed that the expression of PCNA was
present in the basal and suprabasal cell layers of cholesteatoma
matrix, while it was expressed only in the basal layer of the
skin.20,22
In the present study, we used PCNA as proliferation mar-
ker to compare pediatric and adult specimens. PCNA expres-
sion was signiﬁcantly higher in pediatric specimens compared
to adult specimens. The expression was higher in both matrix
and perimatrix. In the matrix, the mean expression of adult
specimens was 17.75 ± 12.08, while the mean of pediatric
specimens was 32.82 ± 17.09. In the perimatrix, the mean
expression of adult specimens was 14.77 ± 17.28, while the
mean of pediatric specimens was 24.22 ± 22.61. Increased
expression of PCNA signiﬁes increased proliferation, which
may be correlated with increased invasiveness and destructive
behavior of pediatric cholesteatomas.
In the present study, cholesteatoma with higher prolifera-
tion scores (higher PCNA expression) showed to be more
aggressive (greater extension and more invasion). Therefore,
PCNA expression may predict the severity of the disease. On
the other hand, Hassmann-Poznanska et al.23 found no corre-
lation between results of PCNA expression in cholesteatoma
and clinical parameters.
The differences in the results of these various studies re-
vealed that the increased proliferation is not the only explana-
tion of the aggressive behavior of pediatric cholesteatoma.
Therefore we agree with Sade et al. that the clinically
observed aggressive behavior of pediatric cholesteatoma may
depend on other parameters, such as the disturbance of middle
ear ventilation, the preformed paths for cholesteatoma exten-
sion in the middle ear, and/or reduced calcium salt content
of the pediatric bone matrix.247. Conclusion
The degree of ﬁbrosis was signiﬁcantly higher in adult speci-
mens compared to pediatric specimens. This may indicate that
adult cholesteatoma is more in reparative process and is less
invasive. PCNA expression was signiﬁcantly higher in the ma-
trix and perimatrix of pediatric cholesteatoma compared to
12 M. Bassiouny et al.adult cholesteatoma. This may be correlated with the increased
proliferation of pediatric cholesteatoma. Pediatric cholestea-
toma was more aggressive and more invasive than adult
cholesteatoma.
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